Details for New Drug Application (NDA): 202061
✉ Email this page to a colleague
NDA 202061 describes BENZPHETAMINE HYDROCHLORIDE, which is a drug marketed by Avet Lifesciences, Chartwell, Epic Pharma Llc, Impax Labs, Kvk Tech, Scinopharm Taiwan, Specgx Llc, and Tedor Pharm, and is included in nine NDAs. It is available from six suppliers. Additional details are available on the BENZPHETAMINE HYDROCHLORIDE profile page.
The generic ingredient in BENZPHETAMINE HYDROCHLORIDE is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
The generic ingredient in BENZPHETAMINE HYDROCHLORIDE is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
Summary for 202061
| Tradename: | BENZPHETAMINE HYDROCHLORIDE |
| Applicant: | Avet Lifesciences |
| Ingredient: | benzphetamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202061
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Jan 27, 2012 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
